Evaluation of combination therapy in animal models of cerebral ischemia

Journal of Cerebral Blood Flow and Metabolism

Volumn 32, Issue 4, 2012, Pages 585-597

  O'Collins, Victoria E ^a   MacLeod, Malcolm R ^b   Donnan, Geoffrey A ^a   Howells, David W ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Animal models; cerebral ischemia; neuroprotection; stroke; therapeutics

Indexed keywords

APTIGANEL; ASCORBIC ACID 2 [3,4 DIHYDRO 2,5,7,8 TETRAMETHYL 2 (4,8,12 TRIMETHYLTRIDECYL) 2H 1 BENZOPYRAN 6 YL HYDROGEN PHOSPHATE] POTASSIUM; ATORVASTATIN; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BATROXOBIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CAFFEINE; CANDESARTAN; CITICOLINE; CLENBUTEROL; CYCLOHEXIMIDE; CYCLOSPORIN A; DEXAMETHASONE; DEXANABINOL; DEXTROMETHORPHAN; DEXTRORPHAN; DIMETHYLTHIOUREA; DIZOCILPINE; ELIPRODIL; ERYTHROPOIETIN; ESTROGEN; FLUOSOL; FLUOXETINE; GINKGO BILOBA EXTRACT; GLUCOSE; GRANULOCYTE COLONY STIMULATING FACTOR; INSULIN; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; TISSUE PLASMINOGEN ACTIVATOR; UNINDEXED DRUG;

BLOOD CLOT LYSIS; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CLINICAL TRIAL (TOPIC); CRANIECTOMY; DISEASE MODEL; HYPOTHERMIA; META ANALYSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW;

ANIMALS; BRAIN ISCHEMIA; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; DISEASE MODELS, ANIMAL; EVALUATION STUDIES AS TOPIC; HUMANS; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 84859428889     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2011.203     Document Type: Review

References (52)

1. Adams HP, Adams RJ, Brott T, Del Zoppo GJ, Furlan AJ, Goldstein LB, Grubb RL, Higashida R, Kidwell CS, Kwiatkowski TG, Marler JR, Hademenos GJ (2003) Guidelines for the early management of patients with ischemic stroke. A scientific statement from the Stroke Council of the American Stroke Association. Stroke 34:1056-108
2. Adams Jr HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF (2007) Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38:1655-711 (Pubitemid 46691097)
3. Alder N, Fenty J,Warren F, Sutton AJ, Rushton L, Jones DR, Abrams KR (2006) Meta-analysis of mortality and cancer incidence among workers in the synthetic rubberproducing industry. Am J Epidemiol 164:405-20 (Pubitemid 44576608)
4. Asahi M, Asahi K, Wang X, Lo EH (2000) Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats. J Cereb Blood Flow Metab 20:452-7 (Pubitemid 30164888)
5. Bochelen D, Rudin M, Sauter A (1999) Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. J Pharmacol Exp Ther 288:653-9 (Pubitemid 29119677)
6. Brimble MA, Levi MS (2006) A review of agents patented for their neuroprotective properties. Recent Patents on CNS Drug Discovery 1:139-46
7. Brown MJ, Cruickshank JK, Dominiczak AF, MacGregor GA, Poulter NR, Russell GI, Thom S, Williams B (2003) Better blood pressure control: how to combine drugs. J Human Hypertension 17:81-6 (Pubitemid 36292361)
8. Byrne BE (2003) Drug interactions: a review and update. Endodontic Topics 4:9-21
9. Carter LP, Guthkelch AN, Orozco J, Temeltas O (1992) Influence of tissue plasminogen-activator and heparin on cerebral-ischemia in a rabbit model. Stroke 23:883-8
10. Cheng YD, Al-Khoury L, Zivin JA (2004) Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx 1:36-45 (Pubitemid 46589340)
11. Corn BW (2004) Advances in the combination of radiation therapy and chemotherapy against cancer. Drug News Perspect 17:469-75 (Pubitemid 39387923)
12. Danton GH, Dietrich WD (2004) The search for neuroprotective strategies in stroke. AJNR Am J Neuroradiol 25:181-94 (Pubitemid 38235294)
13. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Controlled Clin Trials 7:177-88 (Pubitemid 17189972)
14. Duval S, Tweedie R (2000) Trim and fill: a simple funnelplot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455-63 (Pubitemid 30422636)
15. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res ed) 315:629-34 (Pubitemid 27387172)
16. European Ad Hoc Consensus Group: Neuroprotection as initial therapy in acute stroke. Third Report of an Ad Hoc Consensus Group Meeting (1998) Cerebrovasc Dis 8:59-72
17. Fang PC, Barbay S, Plautz EJ, Hoover E, Strittmatter SM, Nudo RJ (2010) Combination of NEP 1-40 treatment and motor training enhances behavioral recovery after a focal cortical infarct in rats. Stroke 41:544-9
18. Fisher M (2003) Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3. Stroke 34:1539-46 (Pubitemid 36693531)
19. Fisher M, Albers GW, Donnan GA, Furlan AJ, Grotta JC, Kidwell CS, Sacco RL, Wechsler LR (2005) Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable. Stroke 36:1808-13 (Pubitemid 41098783)
20. Fisher M, Hanley DF, Howard G, Jauch EC,Warach S (2007) Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes. Stroke 38:245-8 (Pubitemid 46184280)
21. Fujiwara N, Murata Y, Arai K, Egi Y, Lu J, Wu O, Singhal AB, Lo EH (2009) Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke. BMC Neurosci 10:79
22. Higgins JP, Green S (2006) (eds). Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. Chichester, UK: John Wiley & Sons Ltd Higgins JP
23. Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ (Clin Res ed) 327:557-60 (Pubitemid 37088507)
24. Lees KR (2002) Management of acute stroke. Lancet Neurol 1:41-50 (Pubitemid 37159197)
25. Lekieffre D, Benavides J, Scatton B, Nowicki JP (1997) Neuroprotection afforded by a combination of eliprodil and a thrombolytic agent, rt-PA, in a rat thromboembolic stroke model. Brain Res 776:88-95 (Pubitemid 28018461)
26. Liu R, Liu Q, He SQ, Simpkins JW, Yang SH (2010) Combination therapy of 17 beta-estradiol and recombi-nant tissue plasminogen activator for experimental ischemic stroke. J Pharmacol Exp Ther 332:1006-12
27. Macleod MR, O'Collins T, Horky LL, Howells DW, Donnan GA (2005a) Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke. J Pineal Res 38:35-41 (Pubitemid 40139308)
28. Macleod MR, O'Collins T, Horky LL, Howells DW, Donnan GA (2005b) Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. J Cereb Blood Flow Metab 25:713-21 (Pubitemid 40705606)
29. Macleod MR, O'Collins T, Howells DW, Donnan GA (2004) Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 35:1203-8 (Pubitemid 38543544)
30. Macleod MR, van der Worp HB, Sena ES, Howells DW, Dirnagl U, Donnan GA (2008) Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke 39:2824-9
31. Maeda M, Furuichi Y, Noto T, Matsuoka N, Mutoh S, Yoneda Y (2009) Tacrolimus (FK506) suppresses rt-PAinduced hemorrhagic transformation in a rat thrombotic ischemia stroke model. Brain Res 1254:99-108
32. Meden P, Overgaard K, Pedersen H, Boysen G (1994) Effect of hypothermia and delayed thrombolysis in a rat embolic stroke model. Acta Neurol Scand 90:91-8 (Pubitemid 24261203)
33. Moleac (2007) WIPO: (WO/2007/106049) Combination therapy for treatment of patients with neurological disorders and cerebral infarction. http://www.wipo. int/pctdb/en/
34. Murata Y, Rosell A, Scannevin RH, Rhodes KJ, Wang X, Lo EH (2008) Extension of the thrombolytic time window with minocycline in experimental stroke. Stroke 39:3372-7
35. Neurokey A/S (2007) WIPO: (WO 2008/040361) Use of a combination of hypothermia inducing drugs. http://www.wipo.int/pctdb/en/
36. Novartis (2007) WIPO: (WO/2007/041362) 2-AMINO-7, 8-DIHYDRO-6H-PYRIDO[4, 3-D] PYRIMIDIN-5-ONES. http://www.wipo.int/pctdb/en/
37. O'Collins VE, Donnan GA, Macleod MR, Howells DW (2009) Scope of preclinical testing versus quality control within experiments. Stroke 40:e497
38. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW (2006) 1,026 experimental treatments in acute stroke. Ann Neurol 59:467-77 (Pubitemid 43358067)
39. Ramanath VS, Eagle KA (2007) Evidence-based medical therapy of patients with acute coronary syndromes. Am J Cardiovasc Drugs 7:95-116 (Pubitemid 46790266)
40. Rogalewski A, Schneider A, Ringelstein EB, Schabitz WR (2006) Toward a multimodal neuroprotective treatment of stroke. Stroke 37:1129-36
41. Saver JL, Kalafut M (2001) Combination therapies and the theoretical limits of evidence-based medicine. Neuroepidemiology 20:57-64 (Pubitemid 32453722)
42. Savitz SI (2007) A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke. Exp Neurol 205:20-5 (Pubitemid 46621180)
43. Sena ES, van der Worp HB, Bath PM, Howells DW, Macleod MR (2010) Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol 8:e1000344
44. Sereghy T, Overgaard K, Boysen G (1993) Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats. Stroke 24:1702-8 (Pubitemid 23315879)
45. STB-42 (1998). Stata Technical Bulletin (STB) 42. College Station, TX: Texas A & M University
46. Suzuki M, Sasamata M, Miyata K (2003) Neuroprotective effects of YM872 coadministered with t-PA in a rat embolic stroke model. Brain Res 959:169-72 (Pubitemid 35435418)
47. Teichner A, Ovadia H, Lavie G, Leker RR (2003) Combination of dexanabinol and tempol in focal cerebral ischemia: is there a ceiling effect? Exp Neurol 182:353-60 (Pubitemid 36937088)
48. Thompson SG, Higgins JP (2002) How should metaregression analyses be undertaken and interpreted? Stat Med 21:1559-73 (Pubitemid 34746063)
49. Thompson SG, Sharp SJ (1999) Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 18:2693-708 (Pubitemid 29481404)
50. Toung TJ, Chen T-Y, Littleton-Kearney MT, Hurn PD,Murphy SJ (2004) Effects of combined estrogen and progesterone on brain infarction in reproductively senescent female rats. J Cereb Blood Flow Metab 24:1160-6 (Pubitemid 39332155)
51. Zhang L, Zhang ZG, Buller B, Jiang J, Jiang YT, Zhao DP, Liu XS, Morris D, Chopp M (2010) Combination treatment With VELCADE and low-dose tissue plasminogen activator provides potent neuroprotection in aged rats after embolic focal ischemia. Stroke 41: 1001-1007
52. Zhao CS, Puurunen K, Schallert T, Sivenius J, Jolkkonen J (2005) Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury. Behav Brain Res 158:211-20 (Pubitemid 40208467)